Show simple item record

dc.contributor.authorO'Connell, K.
dc.contributor.authorKelly, S.B.
dc.contributor.authorFogarty, E.
dc.contributor.authorDuggan, M.
dc.contributor.authorBuckley, L.
dc.contributor.authorHutchinson, M.
dc.contributor.authorMcGuigan, C.
dc.contributor.authorTubridy, N.
dc.date.accessioned2014-09-22T14:07:08Z
dc.date.available2014-09-22T14:07:08Z
dc.date.issued2014-09
dc.identifier.citationO'Connell K et al. Economic costs associated with an MS relapse. Multiple Sclerosis Rel Disord 2014 [published online 16 September 2014]en_GB
dc.identifier.issn22110348
dc.identifier.doi10.1016/j.msard.2014.09.002
dc.identifier.urihttp://hdl.handle.net/10147/326361
dc.description.abstractThis was an prospective audit composed of medical chart review and patient questionnaire. Relapses were stratified into 3 groups: low, moderate and high intensity. Age, gender, MS subtype, disease duration, expanded disability status scale (EDSS) score, disease modifying therapy (DMT) use and employment status were recorded. Direct costs included GP visits, investigations, clinic visit, consultations with medical staff, medication and admission costs. Indirect costs assessed loss of earnings, partner's loss of earnings, childcare, meals and travel costs.
dc.language.isoenen
dc.publisherMultiple Sclerosis and Related Disordersen_GB
dc.relation.urlhttp://linkinghub.elsevier.com/retrieve/pii/S2211034814001060en_GB
dc.rightsArchived with thanks to Multiple Sclerosis and Related Disordersen_GB
dc.subjectMULTIPLE SCLEROSISen_GB
dc.subjectECONOMIC FACTORen_GB
dc.titleEconomic costs associated with an MS relapseen_GB
dc.typeArticleen
dc.contributor.departmentNational Centre for Pharmacoeconomics, Dublin, Ireland.en_GB
dc.identifier.journalMultiple Sclerosis and Related Disordersen_GB
dc.description.fundingNo fundingen
dc.description.provinceLeinsteren
dc.description.peer-reviewpeer-reviewen
html.description.abstractThis was an prospective audit composed of medical chart review and patient questionnaire. Relapses were stratified into 3 groups: low, moderate and high intensity. Age, gender, MS subtype, disease duration, expanded disability status scale (EDSS) score, disease modifying therapy (DMT) use and employment status were recorded. Direct costs included GP visits, investigations, clinic visit, consultations with medical staff, medication and admission costs. Indirect costs assessed loss of earnings, partner's loss of earnings, childcare, meals and travel costs.


Files in this item

Thumbnail
Name:
Publisher version

This item appears in the following Collection(s)

Show simple item record